Neoindicate
Wellington, US · 1 known investors
Neoindicate develops biomarkers and agents that target tumor microenvironments for cancer diagnosis, imaging, and treatment across multiple cancer types including brain tumors, melanoma, and breast cancer.
Investors · 1
Frequently asked questions
- What does Neoindicate do?
- Neoindicate develops biomarkers and agents that target tumor microenvironments for cancer diagnosis, imaging, and treatment across multiple cancer types including brain tumors, melanoma, and breast cancer.
- Who are Neoindicate's investors?
- Neoindicate's investors include CWRU Technology Ventures.
- Where is Neoindicate headquartered?
- Neoindicate is headquartered in Wellington, US.